Everything About ___
Live briefing

Everything about Enhancer-FACS-seq

Enhancer-FACS-seq (eFS), developed by the Bulyk lab at Brigham and Women’s Hospital and Harvard Medical School, is a highly parallel enhancer assay that aims for the identification of active, tissue-specific transcriptional enhancers, in the context of whole Drosophila melanogaster embryos. This technology replaces the use of microscopy to screen for tissue-specific enhancers with fluorescence activated cell sorting (FACS) of dissociated cells from whole embryos, combined with identification by high-throughput Illumina sequencing. Wikipedia →

🧭 Start here: a 6-step reading path

  1. Read the overview: Enhancer-FACS-seqA 5-minute orientation
  2. Skim a recent paper: STAT3 Facilitates Super Enhancer Formation to Promote Fibroblast‐To‐Myofibroblast Differentiation by the Analysis of ATAC ‐Seq, RNA ‐Seq and ChIP ‐SeqInfluential work since 2022
  3. Read the landmark paper: Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCited 2,021 times
  4. Go sideways: Enhancer (genetics)A closely related topic
  5. Go sideways: STARR-seqA closely related topic

📖 Definitions

No dictionary entry for this exact phrase.

🏆 Landmark papers (most cited)

🆕 Influential since 2022

📚 Books worth reading

Open Library didn't respond; try again in a moment.

🔗 Related topics